Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

BrightSpring Health Services (BTSG) Other financing activities (2023 - 2024)

BrightSpring Health Services filings provide 2 years of Other financing activities readings, the most recent being $3.6 million for Q4 2024.

On a quarterly basis, Other financing activities rose 2491.97% to $3.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $47.0 million, a 6300.68% increase, with the full-year FY2024 number at $47.0 million, up 6300.68% from a year prior.
Other financing activities hit $3.6 million in Q4 2024 for BrightSpring Health Services, up from $509000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $43.0 million in Q1 2024 to a low of $22000.0 in Q2 2024.